|
|
|
|
Thursday's market movers including ValiRx |
|
Ημερομηνία: 13/06/2013 06:52   - Με: bambaec   - 70 Προβολές   - Κατηγορία: Διάφορα
The firm has agreed an expanded protocol for its first-in-man studies on VAL 201 - the drug candidate being developed for prostate cancer\nLON:BAO
|
|
Σχόλια... |
|
Σχετικά βίντεο... |
|
|
|
|
|
|
|